Relaxation |
|
|
Clinical Trial: Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to compare the effectiveness of relaxation therapy and tai chi in treating the symptoms of rheumatoid arthritis (RA).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Arthritis, Rheumatoid | Behavior: Tai Chi Chih Behavior: Relaxation training | Phase II Phase III |
MedlinePlus related topics: Rheumatoid Arthritis
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Efficacy Study
Official Title: Efficacy of CAM Interventions in Rheumatoid Arthritis
Expected Total Enrollment: 100
Study start: November 2004; Expected completion: November 2007
Last follow-up: January 2007; Data entry closure: March 2007
RA is a debilitating disease characterized by inflammation of the joints, leading to chronic pain, loss of function, and disability. Complementary and alternative medicine (CAM) treatments are being used with increased frequency by patients with chronic pain and rheumatic diseases to relieve their symptoms. While patients find these treatments helpful, there is limited scientific evidence of the effectiveness of these interventions. This study will compare relaxation therapy (a commonly used treatment for RA) to tai chi chih (a combination of slow, deliberate movements and meditation) in treating the symptoms of RA.
Participants will be randomly assigned to receive 12 weeks of either relaxation therapy or tai chi chih. At study entry and Weeks 6 and 12, participants will complete questionnaires about their RA symptoms, health functioning, overall quality of life, and complete a brief medical exam.
Eligibility
Ages Eligible for Study: 18 Years - 85 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Active adult onset rheumatoid arthritis
- Stable on disease-modifying antirheumatic drugs (DMARDs) or biologic medications
- Able to walk without use of an assistive device
- Resides in greater Los Angeles area
- Willing and able to comply with study requirements
Exclusion Criteria:
- Uncontrolled or untreated medical conditions
- Frequent or uncontrolled disease flares
- Use of certain medications any medical condition deemed by the investigators to interfere with either the patient's safe participation or interpretation of the study data
Location and Contact Information
California
University of California, Los Angeles Medical Center, Los Angeles, California, 90095, United States; Recruiting
Jennifer Pike, PhD, Principal Investigator
Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States; Recruiting
Jennifer Pike, PhD, Principal Investigator, University of California, Los Angeles
More Information
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: November 15, 2004
ClinicalTrials.gov Identifier: NCT00096759
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -

